Citigroup Maintains Buy on Wix.com, Lowers Price Target to $250

Citigroup analyst Nicholas Jones maintains Wix.com (NASDAQ:WIX) with a Buy and lowers the price target from $320 to $250.

byBenzinga Newsdesk

August 17, 2021

1 minute read

Citigroup analyst Nicholas Jones maintains Wix.com (NASDAQ:WIX) with a Buy and lowers the price target from $320 to $250.

Verrica Pharmaceuticals Q2 EPS $(0.35) Up From $(0.38) YoY

By Benzinga Newsdesk

August 10, 7:39 AM

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.35) per share. This is a 7.89 percent increase over losses of $(0.38) per share from the same period last year.

VRCA

Splash Beverage’s Distribution Channel Expansion Likely To Push Growth, Says Analyst

By Shivani Kumaresan

December 16, 12:43 PM

EF Hutton analyst Michael Albanese reiterated a Buy rating on the shares of Splash Beverage Group Inc (NYSE:SBEV) and lowered the price…

SBEV

BellRock Brands To Produce Mary’s Medicinals Cannabis Products in Maryland Via Deal With Curio Wellness

By Jelena Martinovic

October 21, 8:11 AM

Cannabis-focused consumer packaged goods company BellRock Brands Inc. (CSE: BRCK.U)(OTCEM: DXBRF) announced Thursday that the company has entered into a licensing agreement with Curio Wellness to manufacture and distribute its iconic Mary's Medicinals line to cannabis retailers in Maryland.

CSE:BRCK